ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 59 filers reported holding ATRECA INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,955 | -73.4% | 15,156 | +0.0% | 0.00% | – |
| Q2 2023 | $14,852 | -59.0% | 15,155 | -52.4% | 0.00% | – |
| Q1 2023 | $36,260 | +42.4% | 31,807 | 0.0% | 0.00% | – |
| Q4 2022 | $25,465 | -49.1% | 31,807 | -0.4% | 0.00% | – |
| Q3 2022 | $50,000 | -12.3% | 31,937 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | -84.7% | 31,937 | -72.8% | 0.00% | – |
| Q1 2022 | $372,000 | -2.1% | 117,226 | -6.4% | 0.00% | – |
| Q4 2021 | $380,000 | -51.5% | 125,214 | -0.4% | 0.00% | – |
| Q3 2021 | $783,000 | +2.0% | 125,690 | +39.3% | 0.00% | – |
| Q2 2021 | $768,000 | -52.9% | 90,241 | -15.2% | 0.00% | – |
| Q1 2021 | $1,631,000 | -8.3% | 106,442 | -3.4% | 0.00% | – |
| Q4 2020 | $1,779,000 | +45.3% | 110,158 | +25.6% | 0.00% | – |
| Q3 2020 | $1,224,000 | -17.5% | 87,679 | +25.8% | 0.00% | – |
| Q2 2020 | $1,483,000 | +86.1% | 69,693 | +44.6% | 0.00% | – |
| Q1 2020 | $797,000 | +166.6% | 48,191 | +149.8% | 0.00% | – |
| Q4 2019 | $299,000 | +109.1% | 19,294 | +64.6% | 0.00% | – |
| Q3 2019 | $143,000 | – | 11,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,396,644 | $12,000,000 | 1.84% |
| EcoR1 Capital, LLC | 2,426,685 | $20,675,000 | 0.77% |
| Boxer Capital, LLC | 2,202,333 | $18,764,000 | 0.66% |
| Aisling Capital Management LP | 387,653 | $3,303,000 | 0.53% |
| Samsara BioCapital, LLC | 396,835 | $3,381,000 | 0.42% |
| CM Management, LLC | 60,000 | $511,000 | 0.37% |
| Redmile Group, LLC | 2,460,268 | $20,961,000 | 0.31% |
| Sio Capital Management, LLC | 113,455 | $967,000 | 0.24% |
| Parkman Healthcare Partners LLC | 100,628 | $857,000 | 0.19% |
| Ikarian Capital, LLC | 250,000 | $2,130,000 | 0.17% |